A health ministry panel has added a new highly effective, but expensive, hepatitis C virus drug to the national health insurance scheme, giving high hopes for patients who have had to endure painful interferon injections.
The tablet drug Harvoni, developed by U.S.-based Gilead Sciences Inc., is expected to revolutionize the treatment of patients with hepatitis C genotype 1, which accounts for about 70 percent of all hepatitis C patients in Japan.
A daily dose of one pill set at ¥80,171 will starting Monday be covered by the insurance, limiting the patient cost to about ¥20,000 a month. Read more.... Read our Hepatitis C Around the World on Japan: go here....
Showing posts with label access to Harvoni. Show all posts
Showing posts with label access to Harvoni. Show all posts
Thursday, August 27, 2015
Sunday, July 19, 2015
Port Aransas man with hep c fights insurance company
"I want to live. I want to be healthy. I want my liver to be cured now, not when it's almost impossible to cure and then be put on the liver transplant list."
PORT ARANSAS -A Port Aransas man is literally fighting for his life.
Richard Titus, 56, has been duking it out with his health insurance company to cover a treatment that could save his life.
Titus recently discovered he has Hepatitis C, a liver infection caused by the Hepatitis C virus.
Read more...
Monday, June 15, 2015
Local woman sues Anthem Blue Cross for denying Hepatitis C drug
LOS ANGELES (KABC) --A Los Angeles woman is suing Anthem Blue Cross claiming the insurance company is denying her coverage for a Hepatitis C drug that could cure her.
Jane Blumenfeld said it has been 14 years of fear and uncertainty since she was diagnosed with Hepatitis C. She does not know when her health could take a turn for the worst.
It all started when she tried to donate blood.
Read more...
Subscribe to:
Posts (Atom)